ANDA 76895, held by Pharmobedient. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 76895 (Prednisolone Sodium Phosphate), held by Pharmobedient, was first approved by FDA on Oct 4, 2004, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 4, 2004 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 15MG BASE/5ML · solution;oral | Prednisolone Sodium Phosphate | Discontinued |
| Jun 5, 2024 | Supplement 19Labeling · Standard review | Approved | None posted |
| Aug 13, 2008 | Supplement 4Labeling | Approved | None posted |
| Oct 4, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters